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aged 60.2±8.0 in average. Mortality was obtained from routine statistics and
median follow-up was 7.2 years. The association of adiponectin with mortality
was determined by a cox proportional hazard model. 
Results: Adiponectin (mean: 5.6±4.3 microg/mL) was significantly associ-
ated (p=0.001) with RHR (mean: 63.8±11.9 beats/mn) and LVEF (median:
55%, p=0.001) but not with the severity of coronary lesions (Gensini and
Jeopardy scores). After multivariable adjustment for age, tobacco consump-
tion, physical activity, history of diabetes, hypertension and dyslipidaemia,
waist girth, ApoA1, length of CHD and severity scores, adiponectin remained
significantly associated with mortality HR: 1.05 (1.01-1.09), p=0.008. In
people with RHR 61.5 beat/mn and LVEF <40% HRs increased significantly
from 2.70 (0.93-7.84) when adiponectin was below median (4.4 microg/mL)
to 7.29 (3.60-14.7) when it was above. The increased risk was similar when
RHR was below 61.5 microg/mL and LVEF below 40%, (from 2.66 (0.73-
9.77) to 6.80 (2.48-18.6)) or in men with RHR 61.5 microg/mL and LVEF
40%, although the strength of the relationship was smaller (from 1.22 (0.59-
2.51) to 2.79 (1.43-5.41)).
Conclusion: High adiponectin levels were associated with long term mor-
tality in French men suffering from CHD after multivariable adjustment. This
prognostic value remains significant whatever the severity of CHD.
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Background: Patients with psoriasis would be exposed to a high risk of
atherosclerosis. This study aimed to assess ten-year cardiovascular risk for
coronary heart disease in Tunisian psoriatic patients and to test the role of pso-
riasis severity and duration on cardiovascular risk.
Methods: A case-control study included 202 psoriatic patients and
216 healthy controls. Risk of coronary heart disease was estimated using the
Framingham risk score algorithm.
Results: Psoriatic patients had higher ten-year Framingham risk score
(12.71±3.81 vs. 7.45±6.66; p<0.001) than controls. Besides, a high risk score
(20% to 40%) was more frequent in psoriatic patients compared with controls
(18.3% vs. 6.5%; p<0.001) and a very high risk (>40%) was noted in 5.9% of
psoriatic patients versus 0% in controls. The cardiovascular risk tend to
increase with severity of psoriasis (10.05±11.22, 14.32±13.97 and
15.46±16.26 for low, high and very high risk levels, respectively). But, no
relationship wad found with duration of psoriasis.
Conclusion: Tunisian psoriatic patients have significantly greater risk of
developing coronary heart disease than controls. The more severe is the pso-
riasis; the higher the risk. Patients with psoriasis should be closely followed
for cardiovascular disease and preventive measures specific interventions
should be initiated according to guidelines in psoriatic patients
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Purpose: Elevated resting heart rate (HR) during the hospitalization for
acute myocardial infarction (MI) is an independent predictor of mortality.
However, there is no study that ascertained HR at early follow-up visit after
the introduction of beta blockers (BB), during the first year after MI. Thus,
our aim was to evaluate the prognostic impact of resting HR at early follow-
up visit after MI in first year survivors, independently of BB use.
Methods: In an MI incident cohort (1983-2007), resting HR at early
follow-up (range 1 to 12 months) after MI was retrieved from an ECG data-
base. First year survivor patients were followed from MI until death or last
follow-up. The patient’s population was divided into 5 categories according to
the HR level. Proportional hazards regression examined the association of HR
with mortality after adjustment for confounders, particularly BB.
Results: The mean follow-up of the 1587 included MI patients in sinus
rhythm (mean age 65±14 years, 62% men) was 9 years with 627 deaths.
Patients with elevated HR had a worse baseline risk profile. Elevated HR at
early follow-up was associated with an increased risk of death (table). In
patients taking or not BB, similar results were obtained (table).
Conclusion: Elevated resting HR at early follow-up visit after MI identi-
fies patients at increased risk of death, independently of BB use. This knowl-
edge may help physicians to identify high-risk subjects easily.
Resting HR at early follow-up (in BPM) in First Year Survivors after MI and 
Death (Adjusted Hazard Ratio (95% CI))*
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Aims: Recommendations of the African Type 2 Diabetes Practice Guide-
line for the use of electrocardiogram in the monitoring of people with diabetes
are non-specific. We assessed the prevalence and determinants of electrocar-
diographic abnormalities in people with diabetes in two referral centers in
Cameroon.
Methods: A total of 420 patients with type 2 diabetes (49% men) receiving
chronic care at the Douala General and Yaounde Central hospitals were
included. Electrocardiographic abnormalities were investigated and related to
potential history, clinical and biological determinants with the use of logistic
regression models.
Results: The mean age and median duration of diagnosed diabetes were
56.7 years and 4 years respectively. The main (prevalence – %) electrocardio-
graphic abnormities were: T waves alterations (20.9%), left ventricular hyper-
trophy according to the Cornell product criteria (16.4%), arrhythmia (16.2%),
ischemic heart disease (13.6%), conduction defects (11.9%), QTc prolongation
(10.2%) and ectopic beats (4.8%). Blood pressure variables (systolic, diastolic
and pulse pressure) were consistently associated with all abnormalities. Dia-







at hospital discharge 
(n=456)
HR60 1 1 1
60<HR70 1.5 (1.2-1.9) 1.5 (1.1-2.0) 1.5 (1.0-2.3)
70<HR80 1.6 (1.3-2.1) 1.4 (1.0-1.9) 1.9 (1.2-2.8)
80<HR80 2.1 (1.6-2.7) 1.8 (1.3-2.7) 2.2 (1.4-3.5)
HR>90 2.2 (1.7-2.9) 1.9 (1.3-2.9) 2.5 (1.6-3.9)
*Adjusted for age, sex, body mass index, smoking status, hyperlipidemia, 
hypertension, heart failure, reperfusion/revascularization procedures, 
comorbidity as measured by the Charlson index. Adjustment also for BB at 
discharge in All population.
© Elsevier Masson SAS. All rights reserved.
 
102 Archives of Cardiovascular Diseases Supplements 2012) 4, 100-103
Conclusions: Electrocardiographic abnormalities in this population are domi-
nated by repolarisation, conduction defects and left ventricular hypertrophy, and
are more related to blood pressure indices than diabetes specific factors.
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Purpose: In a large contemporary non experimental cohort of patients (pts)
with known CAD, we assessed long term prognosis associated with statin therapy.
Methods: 783 consecutive male pts hospitalized in 2001-2004 for coro-
nary artery disease were considered. The median follow-up was 7.17 years.
Total mortality was predicted with a Cox proportional hazard model.
Results: Mean age (SD) was 60.2 (8.1), 144 pts (18.4%) were diabetic, mean
glycaemia was 5.9 mmol/l (2.1), 155 pts (19.8%) were smokers, mean blood pres-
sure was 139 (20) / 84 (11) mmHg and median heart rate was 61 bpm [Interquatile
range (IQR)] [57-70]. Mean HDL cholesterol was 43 mg/dl (11), mean LDL cho-
lesterol 124 mg/dl (39) and median triglycerides were 147 mg/dl IQR [109-197].
Mean Cockcroft-Gault creatinine clearance was 87 ml/min and 11 pts (1.4%) had
a severe chronic renal failure (lower than 30 ml/min). Mean left ventricular ejec-
tion fraction was 0.53 (0.13). 88.5% were on antiplatelet therapy, 75.2% on beta-
blocker, and 54.8% on ACE inhibitors or ARB.
Statin therapy was given to 507 pts (66%). The cumulative seven-year total
mortality rate was 17.9% in the whole sample. It was 14.1% in the statin
group but reached 25.2% in pts without statin therapy (p<0.001.).
After multivariate adjustment for age, diabetes, tobacco consumption (none ;
40 pack-years; >40 pack-years), heart rate, left ventricular ejection fraction (>0.5;
0.5 and >0.35; 0.35), duration of CAD, ankle-brachial index (>0.9; 0.9 and
>0.6; 0.6), history of chronic obstructive pulmonary disease or stroke and coro-
nary revascularization, all-cause death was reduced by 46% (95% CI [23%; 63%]
p=0.001) in the group with statin therapy compared to the group without.
Conclusion: In this large observational cohort of non-selected coronary
pts, risk of all-cause death is decreased by more than 50% in pts under statin
therapy.
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Background: Epidemiological studies data indicate that the incidence of
AF, a rapidly growing epidemic burden, varies from 10 to 20 per 1000 person-
years in subjects aged 65 or over. Age is the more potent AF risk factor, due
to combined risk factors and/or predisposing cardiac conditions for AF.
Aims: We aimed to evaluate the clinical and ECG predictors of the inci-
dence of AF in a large contemporary French population-based prospective
cohort study. The clinical evaluation and ECG was realized at admission and
after 4 years of follow-up.
Methods: The study is part of the Three City Study (COVADIS), which
included subjects aged - 65 years and not institutionalised. The incidence was
investigated during a mean follow-up period of 3.65 years.
Results: The overall incidence rate was 4.4/1000 persons per years. Based
on multivariable analyses, the HR was 2.32 [95% CI: 1.41-4.00], p<0.001) for
male gender. Age above 75 years (HR 2.34 [CI 95%: 1.21-4.74], p=0.015),
hypertension (HR 1.84 [95% CI: 1.10-3.10], p=0,02) and history of AF (HR
3.34 [95% CI: 1.12-8.89], p=0.03) were associated with an increased incidence
of AF. ECG-derived parameters, including LV hypertrophy, and the usual clin-
ical risk markers were not associated with AFoccurrence at follow-up.
Conclusion: In a contemporary cohort of elderly subjects, hypertension,
age, history of previous AF and gender are predictors of AF occurrence at
midterm follow-up. No ECG variables were predictors of AF. 
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Objective: Serum uric acid (UA) is reported as an important marker of
hypertension, coronary heart disease, and diabetes. We examined the associa-
tion of serum uric acid (UA) with metabolic syndrome (MS) in a Tunisian
population.
Materiel and methods: The study included 2712 subjects (1228 men and
1484 women), aged from 35 to 70 years and living in the Great Tunis region.
Patients with a history of CVD and Chronic Kidney disease (CKD) were
excluded from the study. The MS was defined according toATPIII. Hyperuri-
cemia was defined as a serum UA value >7.0 mg/dL for males or >6.0 mg/dL
for females.
Results: The prevalence of hyperuricemia, and metabolic syndrome, were
6.1% (9.8% in men and 2.8% in women), and 12.8% (10.2% in men and
15.2% in women), respectively.
Serum uric acid concentrations were significantly and positively correlated
with body mass index, diastolic blood pressure and serum triglyceride concen-
trations; and statistically significant and inverse correlations were noted for
serum uric acid and serum HDL-C concentrations. The prevalence of MS
increased in men and in women according to the quartile of serum uric acid
(p<0.0001). After adjusting for age, smoking status and BMI, multivariate
logistic regression analysis revealed that there was a significant association
between third-quartile uric acid levels and prevalence of metabolic syndrome
in men and in women.
Conclusion: An increase of uric acid constitutes a risk factor for metabolic
syndrome in Tunisian population. Uric acid may be a useful index for initial
risk stratification of patient non-diabetic non hypertensive.
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Abstract: The present study aimed to determine the prevalence of pre-
hypertension (preHTN) and its cardio-metabolic profile in Tunisians, and to
estimate the risk for coronary heart disease (CHD) according to blood pressure
status. A total of 2712 individuals, aged 35 to 69 years were included. The
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